Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
11.08
-0.38 (-3.32%)
At close: Sep 4, 2026, 4:00 PM EDT
10.99
-0.09 (-0.81%)
After-hours: Sep 4, 2026, 7:30 PM EDT
CRBP Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 23.37 | 28.49 | 17.2 | 13.72 | 17 | 25.01 |
Short-Term Investments | 94.57 | 134.78 | 131.86 | 7.18 | 42.19 | 72.64 |
Cash & Short-Term Investments | 117.94 | 163.27 | 149.06 | 20.91 | 59.2 | 97.65 |
Cash Growth | 1.16% | 9.53% | 613.01% | -64.68% | -39.38% | 14.30% |
Other Receivables | 1.5 | 1.5 | - | - | - | - |
Receivables | 1.5 | 1.5 | - | - | - | - |
Prepaid Expenses | 3.31 | 1.52 | 3.63 | 2.45 | 0.79 | 2.37 |
Restricted Cash | - | 0.67 | 0.29 | 0.19 | 0.19 | 0.19 |
Total Current Assets | 122.75 | 166.95 | 152.98 | 23.55 | 60.18 | 100.2 |
Property, Plant & Equipment | 3.85 | 1.24 | 2.52 | 4.04 | 5.5 | 7 |
Other Long-Term Assets | 0.39 | - | 0.39 | 0.69 | 0.63 | 0.52 |
Total Assets | 126.99 | 168.2 | 155.88 | 28.27 | 66.31 | 107.73 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 5.25 | 2.22 | 4.79 | 3.18 | 2.17 | 1.78 |
Accrued Expenses | 15.23 | 16.84 | 5.43 | 11.03 | 6 | 10.09 |
Current Portion of Long-Term Debt | - | - | - | 16.21 | 3.15 | 3.86 |
Current Portion of Leases | 1 | 1.63 | 1.61 | 1.44 | 1.28 | 1.14 |
Other Current Liabilities | - | - | - | 0.04 | 0.04 | 0.13 |
Total Current Liabilities | 21.48 | 20.69 | 11.82 | 31.89 | 12.64 | 17.01 |
Long-Term Debt | - | - | - | - | 15.98 | 15.64 |
Long-Term Leases | 3.27 | - | 1.63 | 3.24 | 4.68 | 5.96 |
Other Long-Term Liabilities | - | - | - | 0.04 | 0.02 | 0.02 |
Total Liabilities | 24.75 | 20.69 | 13.45 | 35.18 | 33.32 | 38.62 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0 | 0 | 0 | - | 0 | 0 |
Additional Paid-In Capital | 715.78 | 702.98 | 619.29 | 429.78 | 425.2 | 418.9 |
Retained Earnings | -613.44 | -555.43 | -476.89 | -436.68 | -392.08 | -349.73 |
Comprehensive Income & Other | -0.11 | -0.05 | 0.04 | -0 | -0.13 | -0.06 |
Shareholders' Equity | 102.24 | 147.5 | 142.43 | -6.91 | 32.99 | 69.11 |
Total Liabilities & Equity | 126.99 | 168.2 | 155.88 | 28.27 | 66.31 | 107.73 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 4.26 | 1.63 | 3.24 | 20.89 | 25.09 | 26.59 |
Net Cash (Debt) | 113.68 | 161.64 | 145.82 | 0.02 | 34.11 | 71.06 |
Net Cash Growth | -0.40% | 10.84% | 694295.24% | -99.94% | -52.00% | 21.26% |
Net Cash Per Share | 6.79 | 12.14 | 13.36 | 0.00 | 8.18 | 17.35 |
Filing Date Shares Outstanding | 19.34 | 17.74 | 12.23 | 10.49 | 4.17 | 4.17 |
Total Common Shares Outstanding | 18.67 | 17.61 | 12.18 | 4.42 | 4.17 | 4.17 |
Working Capital | 101.27 | 146.26 | 141.16 | -8.35 | 47.54 | 83.2 |
Book Value Per Share | 5.48 | 8.38 | 11.69 | -1.56 | 7.91 | 16.56 |
Tangible Book Value | 102.24 | 147.5 | 142.43 | -6.91 | 32.99 | 69.11 |
Tangible Book Value Per Share | 5.48 | 8.38 | 11.69 | -1.56 | 7.91 | 16.56 |
Machinery | 1.15 | 1.13 | 1.13 | 1.2 | 1.38 | 1.43 |
Leasehold Improvements | 3.33 | 3.33 | 3.33 | 3.33 | 3.33 | 3.33 |